BRA30 (HLA-DR) / MCD8 (CD8) dual combination is a direct immunofluorescence reagent can be used for the characterization of leukemia's and lymphomas lymphocytes in whole blood (either lysed or non-lysed) using flow cytometry. The study of activated T cells and the characterization
of leukemias and lymphomas can be performed with the use in combination with, for instance, CD8.